A functional polymorphism in MIR196A2 is associated with risk and prognosis of gastric cancer

Molecular Carcinogenesis

Volumn 52, Issue SUPPL1, 2013, Pages 87-95

  Wang, Shizhi ^a,b   Tao, Guoquan ^a,b   Wu, Dongmei ^a   Zhu, Haixia ^c   Gao, Yan ^a   Tan, Yongfei ^d   Wang, Meilin ^a,b   Gong, Weida ^e   Zhou, Yan ^d   Zhou, Jianwei ^a,b   Zhang, Zhengdong ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c Nantong Cancer Hospital   (China)

^d YIXING PEOPLE S HOSPITAL   (China)

^e Yixing Tumor Hospital   (China)

Author keywords

Gastric cancer; Genetic susceptibility; MIR196A2; Molecular epidemiology; Prognosis

Indexed keywords

MICRORNA; MICRORNA 196A 2; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK REDUCTION; STOMACH CANCER;

GASTRIC CANCER; GENETIC SUSCEPTIBILITY; MIR196A2; MOLECULAR EPIDEMIOLOGY; PROGNOSIS;

ADENOCARCINOMA; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84886254108     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22017     Document Type: Article

References (42)

1. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009; 472:467-477.
2. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009; 374:477-490.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
4. Heidl G, Langhans P, Mellin W, Bunte H, Grundmann E. Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma. J Cancer Res Clin Oncol 1993; 120:95-99.
5. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12:354-362.
6. El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002; 50:368-372.
7. Peek RM, Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2:28-37.
8. Abnet CC, Freedman ND, Hu N, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010; 42:764-767.
9. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11:597-610.
10. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136:215-233.
11. Hall J. Unravelling the general properties of siRNAs: Strength in numbers and lessons from the past. Nat Rev Genet 2004; 5:552-557.
12. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: Rationale, strategies and challenges. Nat Rev Drug Discov 2010; 9:775-789.
13. Esquela-Kerscher A, Slack FJ. Oncomirs-MicroRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
14. Hu Z, Chen J, Tian T, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008; 118:2600-2608.
15. Hu Z, Shu Y, Chen Y, et al. Genetic Polymorphisms in the pre-microRNA flanking region and non-small-cell lung cancer survival. Am J Respir Crit Care Med 2011; 183:641-648.
16. Christensen BC, Avissar-Whiting M, Ouellet LG, et al. Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 2010; 16:3713-3720.
17. Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007; 16:1124-1131.
18. Srivastava K, Srivastava A, Mittal B. Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet 2010; 55:495-499.
19. Qi P, Dou TH, Geng L, et al. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 2010; 71:621-626.
20. Peng S, Kuang Z, Sheng C, Zhang Y, Xu H, Cheng Q. Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 2010; 55:2288-2293.
21. Liu Z, Li G, Wei S, et al. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 2010; 116:4753-4760.
22. Kim MJ, Yoo SS, Choi YY, Park JY. A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer 2010; 69:127-129.
23. Dou T, Wu Q, Chen X, et al. A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol 2010; 136:1853-1859.
24. Tian T, Shu Y, Chen J, et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 2009; 18:1183-1187.
25. Hu Z, Liang J, Wang Z, et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009; 30:79-84.
26. Hoffman AE, Zheng T, Yi C, et al. microRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis. Cancer Res 2009; 69:5970-5977.
27. Chu H, Wang M, Shi D, et al. Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: Evidence from 15 case-control studies. PLoS ONE 2011; 6:e18108.
28. Zhu L, Chu H, Gu D, et al. A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a chinese population. DNA Cell Biol 2012; 31:350-354.
29. Catucci I, Yang R, Verderio P, et al. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat 2010; 31:E1052-E1057.
30. Wang M, Bai J, Tan Y, et al. Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Int J Cancer 2011; 129:1207-1213.
31. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
32. Green FL, Page DL, Fleming ID, et al. Stomach of the digestive system. AJCC cancer staging handbook. 6th edition. New York: Springer Press; 2002. pp. 111-118.
33. Tanzer A, Amemiya CT, Kim CB, Stadler PF. Evolution of microRNAs located within Hox gene clusters. J Exp Zool B Mol Dev Evol 2005; 304:75-85.
34. Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q. MicroRNA-196: Critical roles and clinical applications in development and cancer. J Cell Mol Med 2011; 15:14-23.
35. Wang J, Chen J, Chang P, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2009; 2:807-813.
36. Hui AB, Shi W, Boutros PC, et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest 2009; 89:597-606.
37. Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A, Young BD. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007; 21:912-916.
38. Luthra R, Singh RR, Luthra MG, et al. MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008; 27:6667-6678.
39. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297:1901-1908.
40. Wang Y, Li Z, He C, et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis 2010; 44:191-197.
41. Zhou B, Rao L, Peng Y, et al. Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy. Clin Chim Acta 2010; 411:1287-1290.
42. Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z. Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS ONE 2009; 4:e8003.